Two Mechanisms In One Class
The class divides into two mechanisms. GHRH analogues, such as Sermorelin and CJC-1295, mimic growth-hormone-releasing hormone. Ghrelin-receptor agonists (also called GHRPs), such as Ipamorelin, act through a separate receptor. Researchers frequently study the two mechanisms together because they engage the growth axis through complementary pathways.
- GHRH analogues: Sermorelin, CJC-1295.
- Ghrelin-receptor agonists (GHRPs): Ipamorelin, GHRP-2, GHRP-6.
Why The Combination Is Studied
A common research pairing is a GHRH analogue with a ghrelin-receptor agonist, studied because the two mechanisms address different points in growth-axis signaling. This pairing is one of the most referenced combinations in the growth and longevity research area.
Research Context
These compounds are studied as reference agonists for receptor and signaling research. As research peptides they are for in vitro laboratory research only and are not for human or animal use.
Research Use Only: This guide is informational and describes research-context handling of compounds intended strictly for in vitro laboratory research. Products are not for human or animal consumption, ingestion, or injection, and are not FDA-approved. Nothing here is medical, clinical, or dosing advice.
Frequently Asked Questions
What is a growth hormone secretagogue?
A growth hormone secretagogue is a compound studied for its role in growth-axis signaling. The class splits into GHRH analogues and ghrelin-receptor agonists (GHRPs), which engage the axis through different receptors.
How do Sermorelin, CJC-1295, and Ipamorelin differ?
Sermorelin and CJC-1295 are GHRH analogues that mimic growth-hormone-releasing hormone, while Ipamorelin is a ghrelin-receptor agonist acting through a separate receptor.
Why are a GHRH analogue and a GHRP studied together?
The two mechanisms address different points in growth-axis signaling, so pairing them is one of the most referenced combinations in growth and longevity research.